Post doc position in the USA

January 9, 2012

A Postdoc position is proposed for 2 to 3 years, located in US with a collaborative work between MedImmune Company through R Herbst (US) and Inserm through D Damotte (France).

The objective of the project is to analyse the modulation of lung anti-tumor immune responses by COPD-associated chronic inflammation.

The post doc will develop and implement mouse models of COPD and lung cancer.  Importantly, these models will be combined to investigate the direct impact of COPD and underlying inflammation on lung tumor development. These models will also be used to determine if/how lung tumour changes the COPD-associated inflammatory environment and vice versa.  The project is part of a global study including a human part which will be conducted in Paris (France) in collaboration with another postdoc already recruited.

Applicants should have interest in immunity and cancer, and if possible aware of mouse manipulation.
The beginning of the project is January 2012 but may be flexible beyond 1 to 2 months.
Applications should include a CV and a letter explaining the field of interest. Letters of reference may be useful.
Please send application to Pr Diane Damotte, UMRS 872, Cordeliers Research Centre, 15 Rue de l’Ecole de Médecine 75006 Paris, France. diane.damotte@htd.aphp.fr
or to Dr Ronald Herbst : herbstro@medimmune.com

More News

Teaching Sustainable Development Goals: Methods for Education

January 15, 2025

Funding Opportunities: In Vitro Bioassay Systems Modeling Dysfunction in Neurodegenerative Diseases

January 15, 2025

IVVN ECR Career Development Fellowship Scheme

January 6, 2025

IUIS Executive Committee Statement on Membership Dues

December 20, 2024

ICW 2025 Meeting

December 11, 2024International Complement Society

SLB 2025- Inflammation: A Goldilocks Story

December 10, 2024Society for Leukocyte Biology

Spotlight on Veterinary Immunology: Highlights from ALACI 2024

December 10, 2024Veterinary Immunology Committee (VIC)

Announcing the Recipients of the 2024 Travel4Expertise Grant!

December 2, 2024Gender Equity Committee (GEC)

Clarification on Unaffiliated Events

October 29, 2024